Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-338-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 465, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
BTG3 hsa-miR-338-5p low: 0 high: 7 4 2 2 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr21:17593912-17593933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr21:17593912-17593933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr21:17593912-17593933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr21:17593912-17593933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr21:17593912-17593933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr21:17593912-17593933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr21:17593905-17593927 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Inna Lipchina et al. 2011 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Sebastian Memczak et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
Kishore S et al. 2011 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
TNPO1 hsa-miR-338-5p low: 0 high: 4 3 3 3 0.986
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:72912329-72912353 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72914271-72914292 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:72912452-72912477 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72914271-72914292 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GOLGA4 hsa-miR-338-5p low: 0 high: 4 2 3 2 0.700
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:37366671-37366699 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:37366671-37366699 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr3:37366671-37366699 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr3:37366663-37366680 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TAOK1 hsa-miR-338-5p low: 0 high: 4 3 3 3 0.923
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:29551674-29551696 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:29546688-29546709 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29551674-29551696 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29551674-29551696 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ERO1L hsa-miR-338-5p low: 0 high: 4 2 2 2 0.956
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr14:52643431-52643459 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr14:52640214-52640235 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr14:52640214-52640235 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr14:52640214-52640235 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KLF2 hsa-miR-338-5p low: 0 high: 4 2 2 2 0.911
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:16327395-16327419 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:16327369-16327396 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:16327395-16327419 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:16327369-16327396 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RHOB hsa-miR-338-5p low: 0 high: 4 2 2 2 0.649
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:20448907-20448934 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:20448902-20448926 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:20448907-20448934 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:20448902-20448926 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TAX1BP1 hsa-miR-338-5p low: 0 high: 3 2 3 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:27785245-27785266 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:27785245-27785266 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr7:27785245-27785266 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CLTC hsa-miR-338-5p low: 0 high: 3 3 3 3 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:59694625-59694645 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:59694625-59694645 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:59668778-59668805 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC25A25 hsa-miR-338-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr9:128109112-128109139 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr9:128109112-128109139 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:128109112-128109139 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TLL1 hsa-miR-338-5p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr4:166101794-166101821 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr4:166101788-166101813 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr4:166103690-166103712 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUCKS1 hsa-miR-338-5p low: 0 high: 3 2 2 2 0.613
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:205713587-205713605 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:205713338-205713355 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:205714628-205714646 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATP1A1 hsa-miR-338-5p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:116389436-116389458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:116389436-116389458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:116389436-116389458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EDEM2 hsa-miR-338-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:35142409-35142432 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr20:35134840-35134868 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CBX5 hsa-miR-338-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:54237537-54237557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr12:54238379-54238401 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NFKBIA hsa-miR-338-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr14:35401567-35401595 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:35401567-35401595 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZFAND5 hsa-miR-338-5p low: 0 high: 2 2 2 2 0.788
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr9:72354494-72354518 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:72354494-72354518 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUFIP2 hsa-miR-338-5p low: 0 high: 2 2 2 2 0.869
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:29258906-29258928 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:29262630-29262651 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PTGES3 hsa-miR-338-5p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr12:56663860-56663883 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:56663803-56663827 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CPEB4 hsa-miR-338-5p low: 0 high: 2 2 2 2 0.753
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:173959778-173959804 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:173959778-173959804 HITS-CLIP POSITIVE DIRECT TarBase 7.0